Since pseudopodia are comprised of proteins known to regulate cancer cell interactions with their microenvironment and overall disease progression20, 21, we further reasoned that pseudopodia-enriched (PDE) proteins may generally be good candidate biomarkers of cancer initiation, progression or therapy response. The gene discussed is ALDH7A1; the disease is cancer.